Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls.
Saved in:
| Title: | Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls. |
|---|---|
| Authors: | Salazar-Camelo A; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Vega L; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Fadlallah Y; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Bou Rjeily N; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Balshi A; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Morris B; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Ghajarzadeh M; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Mowry EM; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Waubant E; Department of Neurology, University of California, San Francisco, CA, USA., Nourbakhsh B; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA. |
| Source: | Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2025 Oct; Vol. 31 (11), pp. 1338-1347. Date of Electronic Publication: 2025 Sep 19. |
| Publication Type: | Clinical Trial, Phase IV; Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40970353 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Salazar-Camelo+A%22">Salazar-Camelo A</searchLink>; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Vega+L%22">Vega L</searchLink>; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Fadlallah+Y%22">Fadlallah Y</searchLink>; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Bou+Rjeily+N%22">Bou Rjeily N</searchLink>; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Balshi+A%22">Balshi A</searchLink>; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Morris+B%22">Morris B</searchLink>; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Ghajarzadeh+M%22">Ghajarzadeh M</searchLink>; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Mowry+EM%22">Mowry EM</searchLink>; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Waubant+E%22">Waubant E</searchLink>; Department of Neurology, University of California, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Nourbakhsh+B%22">Nourbakhsh B</searchLink>; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229509185%22">Multiple sclerosis (Houndmills, Basingstoke, England)</searchLink> [Mult Scler] 2025 Oct; Vol. 31 (11), pp. 1338-1347. <i>Date of Electronic Publication: </i>2025 Sep 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase IV; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9509185 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-0970 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213524585%22">13524585 </searchLink><i>NLM ISO Abbreviation: </i>Mult Scler <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40970353 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/13524585251375350 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1338 Titles: – TitleFull: Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Salazar-Camelo A – PersonEntity: Name: NameFull: Vega L – PersonEntity: Name: NameFull: Fadlallah Y – PersonEntity: Name: NameFull: Bou Rjeily N – PersonEntity: Name: NameFull: Balshi A – PersonEntity: Name: NameFull: Morris B – PersonEntity: Name: NameFull: Ghajarzadeh M – PersonEntity: Name: NameFull: Mowry EM – PersonEntity: Name: NameFull: Waubant E – PersonEntity: Name: NameFull: Nourbakhsh B IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2025 Oct Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1477-0970 Numbering: – Type: volume Value: 31 – Type: issue Value: 11 Titles: – TitleFull: Multiple sclerosis (Houndmills, Basingstoke, England) Type: main |
| ResultId | 1 |